Vor Biopharma Inc

Company Profile

Vor Biopharma Inc had its IPO on 2021-02-05 under the ticker symbol VOR.

The company operates in the Healthcare sector and Biotechnology industry. Vor Biopharma Inc has a staff strength of 133 employees.

Stock update

Shares of Vor Biopharma Inc opened at $2.55 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $2.45 - $2.6, and closed at $2.57.

This is a +3.63% increase from the previous day's closing price.

A total volume of 55,049 shares were traded at the close of the day’s session.

In the last one week, shares of Vor Biopharma Inc have slipped by -3.75%.

Vor Biopharma Inc's Key Ratios

Vor Biopharma Inc has a market cap of $178.30 million, indicating a price to book ratio of 1.5785 and a price to sales ratio of 0.

In the last 12-months Vor Biopharma Inc’s revenue was $0 with a gross profit of $0 and an EBITDA of $-108191000. The EBITDA ratio measures Vor Biopharma Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Vor Biopharma Inc’s operating margin was 0% while its return on assets stood at -29.29% with a return of equity of -55.93%.

In Q2, Vor Biopharma Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Vor Biopharma Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-2.07 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Vor Biopharma Inc’s profitability.

Vor Biopharma Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -1.8272. Its price to sales ratio in the trailing 12-months stood at 0.

Vor Biopharma Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$250.99 million

Total Liabilities

$12.72 million

Operating Cash Flow

$0

Capital Expenditure

$399000

Dividend Payout Ratio

0%

Vor Biopharma Inc ended 2024 with $250.99 million in total assets and $0 in total liabilities. Its intangible assets were valued at $250.99 million while shareholder equity stood at $204.45 million.

Vor Biopharma Inc ended 2024 with $0 in deferred long-term liabilities, $12.72 million in other current liabilities, 7000.00 in common stock, $-280629000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $32.21 million and cash and short-term investments were $186.90 million. The company’s total short-term debt was $3,691,000 while long-term debt stood at $0.

Vor Biopharma Inc’s total current assets stands at $191.39 million while long-term investments were $0 and short-term investments were $154.69 million. Its net receivables were $0 compared to accounts payable of $1.65 million and inventory worth $0.

In 2024, Vor Biopharma Inc's operating cash flow was $0 while its capital expenditure stood at $399000.

Comparatively, Vor Biopharma Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$2.57

52-Week High

$7.57

52-Week Low

$2.45

Analyst Target Price

$14.22

Vor Biopharma Inc stock is currently trading at $2.57 per share. It touched a 52-week high of $7.57 and a 52-week low of $7.57. Analysts tracking the stock have a 12-month average target price of $14.22.

Its 50-day moving average was $2.84 and 200-day moving average was $4.62 The short ratio stood at 27.7 indicating a short percent outstanding of 0%.

Around 90.1% of the company’s stock are held by insiders while 9037.8% are held by institutions.